Innoviva
INVA
193 hedge funds and large institutions have $892M invested in Innoviva in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 88 reducing their positions, and 22 closing their positions.
127% more call options, than puts
Call options by funds: $623K | Put options by funds: $274K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
1% less capital invested
Capital invested by funds: $898M → $892M (-$5.46M)
2.8% less ownership
Funds ownership: 107.73% → 104.93% (-2.8%)
3% less funds holding
Funds holding: 199 → 193 (-6)
23% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 22
31% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 88
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.62M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.06M |
| 4 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$2.49M |
| 5 |
Renaissance Technologies
New York
|
+$1.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$12.2M |
| 2 |
Millennium Management
New York
|
-$8.54M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$7.15M |
| 4 |
Man Group
London,
United Kingdom
|
-$5.18M |
| 5 |
BlackRock
New York
|
-$3.32M |
INVA Hedge Fund Activity: Q3 2023 in Review
193 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q3 2023, worth a combined $892M — down 0.61% from $898M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of INVA and 17 opened new positions — a net loss of 5 holders — while 88 trimmed existing stakes and 61 added.
The largest buyer was UBS Group, adding an estimated $5.62M. The largest seller was Pacer Advisors, cutting an estimated $12.2M.
- 193 institutional investors held Innoviva (INVA) as of Q3 2023, down from 199 in Q2 2023.
- Funds reported $892M of Innoviva stock for Q3 2023, down 0.61% quarter-over-quarter.
- 17 funds opened new Innoviva positions in Q3 2023 and 22 closed out, a net change of -5 holders.
- The largest Innoviva buyer in Q3 2023 was UBS Group, an estimated $5.62M added.
- The largest Innoviva seller in Q3 2023 was Pacer Advisors, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2023.